ArticleEye (London, England)2019

Immune reconstitution after alemtuzumab therapy for multiple sclerosis triggering Graves' orbitopathy: a case series.

Jonathan C P Roos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.